Severe asthma remaining well‐controlled after mepolizumab discontinuation: A case report and literature review

Mepolizumab, a humanized anti‐IL‐5 monoclonal antibody used for severe asthma, results in a reduced rate of asthma exacerbation, improved lung function, reduced oral corticosteroid use, and improved quality of life. A 62‐year‐old man using high‐dose inhaled corticosteroid visited our hospital becaus...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuyama, Takahiro, Tomioka, Yuya, Matsuyama, Hiromi, Kamenohara, Yusuke, Tanigawa, Kengo, Dotake, Yoichi, Hagihara, Yoko, Takagi, Koichi, Machida, Kentaro, Inoue, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173049/
https://www.ncbi.nlm.nih.gov/pubmed/37180095
http://dx.doi.org/10.1002/rcr2.1158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173049/
https://www.ncbi.nlm.nih.gov/pubmed/37180095
http://dx.doi.org/10.1002/rcr2.1158

Ejemplares similares